Proteomics Market Size, Scope, Growth Opportunities, Trends by Manufacturers And Forecast to 2031

According to the deep-dive market assessment study conducted by Growth+ Reports, the global proteomics market was pegged at ~US$ 21.7 billion in 2020. The market is expected to witness a CAGR of ~16.2% from 2021 to 2031.

The growing incidence of various infectious diseases and cancer has also played an important role in driving the growth of the global proteomics market. The incidence of cancer is growing across the globe. According to the World Health Organization (WHO), cancer is the second leading cause of death across the globe. According to the American Institute of Cancer Research, about 25 million new cancer cases will be diagnosed each year by 2030. These statistics highlight the rising need for early diagnosis of cancer which can effectively be achieved by applying proteomics. Thus, the rising prevalence of cancer is anticipated to drive the growth of the proteomics market.

Major factors attributing to the growth of proteomics market include the increasing fundings for research activities and growing application of proteomics in drug development as well diagnosis of diseases and monitoring. Moreover, the rising incidence of various diseases, the growing demand for personalized medicines, and the increasing proteomics research activities are some of the other factors playing a pivotal role in driving the proteomics market growth. However, high cost of instruments and reagents is hindering the growth proteomics market to a certain extent.

Get a Sample PDF of the Report - https://growthplusreports.com/inquiry/request-sample/Proteomics-market/7645

Key Players Mentioned in the Global Proteomics Market Research Report:

• Thermo Fisher Scientific Inc
• Merck KGaA, Agilent Technologies, Inc
• Bio-Rad Laboratories, Inc
• General Electric Company
• PerkinElmer Inc
• Danaher Corporation
• Illumina, Inc
• QIAGEN N.V
• Eurofins Scientific Group
• Among others

Global Proteomics Market Segmentation by Product & Services:
• Instrument
• Reagent
• Software & Services

Global Proteomics Market Segmentation by Application:
• Clinical Diagnostics
• Drug Discovery

Key Reasons to Purchase:

(1) To gain insightful analyses of the market and have a comprehensive understanding of the global market and its commercial landscape.

(2) Assess the production processes, major issues, and solutions to mitigate the development risk.

(3) To understand the most affecting driving and restraining forces in the Proteomics Market and its impact in the global market.

(4) Learn about the market strategies that are being adopted by leading respective organizations.

(5) To understand the outlook and prospects for the market.

Key Questions Answered in the Report Include:

(1) This report gives all the information about the industry analysis, revenue, and overview, of this market.

(2) What will be the rate of increase in market size and growth rate by the end of the forecast period?

(3) What are the major global Proteomics Market trends influencing the development of the market?

(4) What are the vital results of SWOT analysis of the major players operating in the Proteomics Market?

(5) What are the potential growth opportunities and threats faced by Major competitors in the market?

Detailed TOC of Global Proteomics Market Growth (Status and Outlook) 2022-2030

1 Scope of the Report

1.1 Market Ecosystem
1.2 Geographic Scope
1.3 Timeline Under Consideration
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Proteomics Market Executive Summary

2.1 World Market Overview
2.1.1 Global Market Size 2022-2030
2.1.2 Market Size CAGR by Region 2020 VS 2028
2.2 Proteomics Market Segment by Type
2.2.1 Type 1
2.2.2 Type 2

Browse the full report now: https://growthplusreports.com/report/Proteomics-market/7645

Manan Sethi
Director, Market Insights
Email: enquire@growthplusreports.com
Phone no: +91 96545 76783
Web: https://growthplusreports.com/

Growth+Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).
Growth+ portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.
We were awarded by the prestigious CEO Magazine as "Most Innovative Healthcare Market Research Company in 2020.

This release was published on openPR.